{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:07:12Z","timestamp":1787814432443,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jvs.2023.01.207","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:22:33Z","timestamp":1676391753000},"page":"1751-1759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-6625","authenticated-orcid":false,"given":"Satoru","family":"Nagatomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2023.01.207_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.207_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.01.207_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.207_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trail","volume":"146","author":"Gou\u00ebffic","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.207_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jcin.2009.04.014","article-title":"Influence of stent fracture on the long-term patency in the femoro-popliteal artery","volume":"2","author":"Iida","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib9","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/01.CIR.0000041632.02514.14","article-title":"Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans","volume":"106","author":"Virmani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.01.207_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1526602818799733","article-title":"Impact of prolonged inflation times during plain balloon angioplasty on angiographic dissection in femoropopliteal lesions","volume":"25","author":"Horie","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study","volume":"74","author":"Liistro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejvs.2020.10.008","article-title":"Drug eluting stent vs. drug coated balloon for native femoropopliteal artery disease: a two centre experience","volume":"61","author":"Lee","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2023.01.207_bib14","doi-asserted-by":"crossref","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcin.2018.12.004","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the chronic total occlusion cohort in the IN.PACT global study","volume":"12","author":"Tepe","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1526602820901723","article-title":"Effectiveness and safety of a paclitaxel-eluting stent for superficial femoral artery lesions up to 190 mm: one-year outcomes of the single-arm IMPERIAL long lesion substudy of the Eluvia drug-eluting stent","volume":"27","author":"Golzar","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jcin.2018.03.046","article-title":"1-year all-comers analysis of the eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty","volume":"11","author":"Bisdas","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","article-title":"2-year outcomes of the eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions","volume":"14","author":"Stavroulakis","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1526602815614555","article-title":"Paclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: three-year results of the DEBATE-ISR study","volume":"23","author":"Grotti","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib22","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jcin.2017.06.018","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT global study de novo in-stent restenosis imaging cohort","volume":"10","author":"Brodmann","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcin.2012.12.118","article-title":"Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents","volume":"6","author":"Zeller","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1526602820966708","article-title":"Long-term effectiveness of a drug-eluting stent for femoropopliteal in-stent restenosis: subanalysis of the Zilver PTX Japan post-market surveillance study","volume":"28","author":"Sugimoto","year":"2021","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1526602814564385","article-title":"Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial","volume":"22","author":"Bosiers","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib26","first-page":"289","article-title":"Jetstream atherectomy in treating femoropopliteal in-stent restenosis: meta-analysis of the JETSTREAM-ISR and JET-ISR trials","volume":"32","author":"Shammas","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1526602815592133","article-title":"Laser atherectomy for treatment of femoropopliteal in-stent restenosis","volume":"22","author":"Armstrong","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib28","first-page":"1168","article-title":"Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention","volume":"82","author":"Armstrong","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jvir.2019.08.014","article-title":"Factors influencing in-stent occlusion after femoropopliteal artery stent placement with intravascular ultrasound evaluation","volume":"31","author":"Kurata","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2023.01.207_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcin.2016.01.007","article-title":"The characteristics of in-stent restenosis after drug-eluting stent implantation in femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy for these lesions","volume":"9","author":"Iida","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jvs.2023.01.207_bib32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcin.2015.03.022","article-title":"1-year results of the ZEPHYR registry (Zilver PTX for the femoral artery and proximal popliteal artery): predictors of restenosis","volume":"8","author":"Iida","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib33","doi-asserted-by":"crossref","first-page":"e002730","DOI":"10.1161\/CIRCINTERVENTIONS.115.002730","article-title":"Femoropopliteal artery stent thrombosis: report from the excellence in peripheral artery disease registry","volume":"9","author":"Banerjee","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib34","doi-asserted-by":"crossref","first-page":"e1107","DOI":"10.4244\/EIJ-D-19-00187","article-title":"Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery","volume":"15","author":"Bradaric","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jvs.2023.01.207_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12928-016-0411-3","article-title":"Potential mechanisms of in-stent occlusion in the femoropopliteal artery: an angioscopic assessment","volume":"32","author":"Ishihara","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jcin.2021.03.030","article-title":"Clinical impact of stent graft thrombosis in femoropopliteal arterial lesions","volume":"14","author":"Ichihashi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1526602818756610","article-title":"Comparison of angiographic dissection patterns caused by long vs short balloons during balloon angioplasty of chronic femoropopliteal occlusions","volume":"25","author":"Tan","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.avsg.2020.10.051","article-title":"Efficacy of rotational atherectomy followed by drug-coated balloon angioplasty for the treatment of femoropopliteal lesions-comparison with sole drug-coated balloon revascularization: two-year outcomes","volume":"73","author":"Rodoplu","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2023.01.207_bib39","doi-asserted-by":"crossref","first-page":"e004848","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/1526602820915244","article-title":"Two-year outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of heavily calcified femoropopliteal lesions","volume":"27","author":"Kokkinidis","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2023.01.207_bib41","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2023.01.207_bib42","article-title":"Intravascular lithotripsy and drug-coated balloon angioplasty for severely calcified femoropopliteal arterial disease","volume":"7","author":"Stavroulakis","year":"2022","journal-title":"J\u00a0Endovasc Ther"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:28:00Z","timestamp":1777573680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521423003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0741521423003622"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2023.01.207","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2023.01.207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}